Lexicon Pharmaceuticals
LXRX
LXRX
124 hedge funds and large institutions have $299M invested in Lexicon Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 40 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less capital invested
Capital invested by funds: $344M → $299M (-$44.9M)
28% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 40
Holders
124
Holding in Top 10
1
Calls
$1.13M
Puts
$289K
Top Buyers
| 1 | +$3.65M | |
| 2 | +$1.74M | |
| 3 | +$1.73M | |
| 4 |
Millennium Management
New York
|
+$1.36M |
| 5 |
Goldman Sachs
New York
|
+$1.18M |
Top Sellers
| 1 | -$1.27M | |
| 2 | -$1.16M | |
| 3 | -$1.12M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$983K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$935K |
